These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 6846359)

  • 21. The intensified drug inspection program: procedures and results.
    Clevenger WL
    Bull Parenter Drug Assoc; 1969; 23(6):263-8. PubMed ID: 5355888
    [No Abstract]   [Full Text] [Related]  

  • 22. Free rein for drug ads? A slowdown in FDA review has left consumers more vulnerable to misleading messages.
    Consum Rep; 2003 Feb; 68(2):33-7. PubMed ID: 12516586
    [No Abstract]   [Full Text] [Related]  

  • 23. Toward more effective drug regulation.
    Schmidt AM
    FDA Consum; 1975 Dec-1976 Jan; 9(10):27-9. PubMed ID: 10316532
    [No Abstract]   [Full Text] [Related]  

  • 24. Institute of Medicine's new drug safety report: implications for Canada.
    Cassels A
    CMAJ; 2006 Dec; 175(12):1515-6. PubMed ID: 17146086
    [No Abstract]   [Full Text] [Related]  

  • 25. FDA inspections of large volume and small volume parenteral manufacturers.
    Shepherd RE
    Bull Parenter Drug Assoc; 1976; 30(5):209-13. PubMed ID: 974306
    [No Abstract]   [Full Text] [Related]  

  • 26. Products in the U.S. pipeline. Pharmaceutical Manufacturers Association.
    Biotechnology (N Y); 1991 Oct; 9(10):947-9. PubMed ID: 1367805
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of regulatory agencies and industry in assessment of the safety of drugs for use in man. United States Food and Drug Administration's viewpoint.
    Ley HL; Desmond FH
    Can Med Assoc J; 1968 Feb; 98(6):318-21. PubMed ID: 5636100
    [No Abstract]   [Full Text] [Related]  

  • 28. The drug efficacy study.
    Provost GP
    Am J Hosp Pharm; 1968 Sep; 25(9):483. PubMed ID: 5671558
    [No Abstract]   [Full Text] [Related]  

  • 29. The drug-potency question.
    Walker JM
    US Navy Med; 1974 Aug; 64(2):26-30. PubMed ID: 4534296
    [No Abstract]   [Full Text] [Related]  

  • 30. Public standards for drugs: reflections on their use by the professions and industry.
    Miller LC
    Hosp Formul; 1976 Mar; 11(3):151-5. PubMed ID: 1026682
    [No Abstract]   [Full Text] [Related]  

  • 31. Reporting drug defects.
    Belson JJ
    Hosp Formul; 1975 Feb; 10(2):78-9. PubMed ID: 10316674
    [No Abstract]   [Full Text] [Related]  

  • 32. America's first drug regulation regime: the rise and fall of the Import Drug Act of 1848.
    Heath WJ
    Food Drug Law J; 2004; 59(1):169-99. PubMed ID: 15212037
    [No Abstract]   [Full Text] [Related]  

  • 33. The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality?
    Marsh DA; Hoar ME
    Contemp Pharm Pract; 1982; 5(2):130-5. PubMed ID: 10317245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New York State and drug lists: a history of confusion.
    Stetler CJ
    Med Mark Media; 1978 Sep; 13(9):36, 38, 40 passim. PubMed ID: 10316687
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmaceutical industry wins "round one" in protections against product liability claims.
    Gatty B
    Hosp Formul; 1995 Apr; 30(4):238, 237. PubMed ID: 10141868
    [No Abstract]   [Full Text] [Related]  

  • 36. Assuring total drug quality.
    Simmons HE
    J Am Pharm Assoc; 1973 Feb; 13(2):96-8. PubMed ID: 4686621
    [No Abstract]   [Full Text] [Related]  

  • 37. Securing the US pharmaceutical supply.
    Somberg JC
    Am J Ther; 2008; 15(3):197. PubMed ID: 18496255
    [No Abstract]   [Full Text] [Related]  

  • 38. "Insuring" the continued solvency of pharmaceutical companies in the face of product liability class actions.
    Chodock R; Yolkut D; Connolly DR
    Tort Trial Insur Pract Law J; 2005; 40(3):997-1017. PubMed ID: 16100814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. World agencies try to stem flood of fake drugs.
    Surendran A
    Nat Med; 2004 Feb; 10(2):111. PubMed ID: 14760401
    [No Abstract]   [Full Text] [Related]  

  • 40. Assuring the quality of the nation's drugs. Interview by William E. Small.
    Michels D
    Am Pharm; 1980 Apr; NS20(4):40-2. PubMed ID: 7386377
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.